Plus   Neg

Carl Zeiss Meditec Sees Growth In FY20 - Quick Facts

Carl Zeiss Meditec AG (CZMWF.PK) Friday said it expects to be able to grow faster than the underlying markets again in fiscal year 2020. The EBIT margin would be in a range from 17 to 19 percent.

Ludwin Monz, President and CEO of Carl Zeiss Meditec, said, "In the medium term, we want to secure the level of earnings we have already achieved and generate an EBIT margin that is sustainably above 18 percent."

The company's outlook follows significant increase in sales and earnings in fiscal year 2019 with growth in all strategic business units and regions.

The EBIT margin in 2019 was 18.1 percent, higher than prior year's 15.4 percent.

Full-year revenue in the EMEA region increased 10.3 percent. The core markets Germany, France and the UK achieved good revenue growth. Revenue in the Americas region grew 8.9 percent and the growth was 20.8 percent in the APAC region.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. U.S. President Donald Trump has issued executive orders to ban Chinese mobile application TikTok as well as WeChat, citing a threat to national security and its economy. China's ByteDance Ltd. owns TikTok, a video-sharing mobile app, while Tencent Holdings Ltd. owns WeChat, a messaging, social media, and electronic payment app.
Follow RTT